Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0717 per EA under NDC 68382073701. Its NADAC has been published 279 times since Feb 24, 2021.
Strength
2.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382073701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213055On Market Since
9/17/2020
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 279 times since Feb 24, 2021, and over the history we have for it it has declined 71.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0717 per EA |
|---|---|
| All-time high | $0.2608 (Apr 14, 2021) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0857 |
| 52-week low | $0.0712 |
| Median price | $0.1428 |
| Average price | $0.1463 |
| Largest weekly change | +59.2% (Nov 22, 2023) |
| Weeks tracked | 279 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Midodrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0717 per EA (NDC 68382073701), effective Jun 24, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 71.7%. It has been tracked across 279 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Feb 24, 2021, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.2608 (Apr 14, 2021), with a median of $0.1428 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MIDODRINE HCL 2.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 68382073701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification